Researchers from Toronto’s Sinai Health have published a study that sheds light on a central mystery for scientists studying ...
Scientists are rethinking how to treat a widespread genetic cholesterol disorder by targeting particle production instead of ...
3don MSNOpinion
Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway
The majority of people who start taking GLP-1 medicines with the hope of losing weight, the drugs can quiet cravings and help ...
Why is the timing of trauma so important? New research shows that estrogen levels in the hippocampus at the moment of stress ...
Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over ...
Hims & Hers faces key FDA decisions on compounded GLP-1/semaglutide peptides—upside if permitted, downside if restricted.
As HuffPost Shopping’s Griffin Wynne puts it: “These [are] a great buy if you hate carrying around a bunch of extra wires and ...
Johnson & Johnson JNJ reported first-quarter financial results on Tuesday. The transcript from the company’s first-quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results